FDA Adverse Event Malfunction Summary report: N

AEROGEN 60ML CONTINUOUS NEBULIZER SYRINGE

MDR report key: 18929058 · Received March 18, 2024

Report

Report Number
MW5152946
Event Type
Malfunction
Date Received
March 18, 2024
Report Date
March 14, 2024
Manufacturer
AEROGEN LTD.
Product Code
CAF
Product Problem
Yes
Report Source
Voluntary report
Reporter Occupation
PHARMACIST
Health Professional
Yes

Narratives

Description of Event or Problem · 0

AEROGEN 60ML SYRINGES ARE UTILIZED FOR CONTINUOUS NEBULIZATION OF EPOPROSTENOL. WE HAVE REPORTS FROM OUR PHARMACY AND RT COLLEAGUES THAT THESE SYRINGES ARE LEAKING. IT HAS BEEN NOTED THAT THE SEAL AROUND THE PLUNGER IS COMPROMISED AND THERE IS THE PRESENCE OF FLUID PASSING THE MEMBRANE. IN ADDITION, OUR PHARMACY TECHNICIANS HAVE REPORTED "WEAKENED" PLUNGERS WHEN FILLING THE SYRINGES. THE MANUFACTURER HAS BEEN CONTACTED AND REQUESTED THE IMPACTED PRODUCT TO BE RETURNED. IMPACTED LOT #S IDENTIFIED: HM20110 AND HM21009. REFERENCE REPORT: MW5152947.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
754428 AEROGEN 60ML CONTINUOUS NEBULIZER SYRINGE NEBULIZER (DIRECT PATIENT INTERFACE) CAF AEROGEN LTD. HM20110

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown